WJPR Citation New

  All Since 2020
 Citation  8502  4519
 h-index  30  23
 i10-index  227  96

Login

Best Article Awards

World Journal of Pharmaceutical Research (WJPR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.
Best Paper Award :
Dr. Dhrubo Jyoti Sen
Download Article: Click Here

Search

Track Your Article

Abstract

AWARENESS, ATTITUDE AND SIGNAL DETECTION OF ANTIDEPRESSANT AND ANXIOLYTIC DRUGS

*Muhammad O. and A. Srinivasan

.

Abstract

Background: Depression and Anxiety have become trending disorder among the people irrespective of age and gender. Research aim is to create awareness among the patients about importance of medication adherence to prevent Adverse event, treatment and adverse event in relation to Anti-Depression and Anxiolytic drugs. Further concentrating on improving their knowledge on adverse event monitoring [ADR] and overlapping of ADR and disease symptoms to improve their quality of life and treatment outcome. Objectives: The primary objective of the study is to evaluate Adverse event related to Anti-Depressant and Anxiolytic drugs. Secondary to check the attitude and create awareness on the treatment and the adverse event. Methodology: An active surveillance was conducted with the sum 210 Depression and Anxiety patients in particular site and collected the data through response on set of questionnaires and spread the awareness about the adverse event and medication adherence among patients by distributing the leaflets which was provided in both English and Tamil for better understanding along with oral counselling regarding the same. Result and conclusion: Among 210 patients, 120 were female and 90 were male. Based on age, Category B [31-50] are more prone to Depression and Anxiety and most patients were aware of the side effect. 22 patients appeared with Adverse event. It was observed that the patients on long term medication had no Adverse effect stating the possibility of resistant to it. Dose of the drug was reduced to the patients who appeared with Adverse event during the period of treatment. Mirtazapine is used for the treatment of depressive disorder.

Keywords: .


[Full Text Article]  [Download Certificate]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More